Baxter Internationalvs.GE HealthCare
BAX vs GEHC · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices, from surgery and cardiology to robotics.
GE HealthCare is about 2.4× larger than Baxter International by market cap; year to date, Baxter International leads (+25.4% vs −21.2%).
Side by side
| BAX | GEHC | |
|---|---|---|
| Market cap | $12.2B | $29B |
| Price | $23.90 | $64.22 |
| Today | −0.3% | −0.7% |
| Return YTD | +25.4% | −21.2% |
| Return 1Y | +4.7% | −13.2% |
| Since June 26, 2026 | +8.4% | −2.3% |
| P/E | — | 14.6 |
| P/S | 1.1 | 1.4 |
| P/B | 2.0 | 2.6 |
Data as of 2026-10-08 · updates daily after U.S. close
Since June 26, 2026: the change in the closing price, from the daily closes Sectivia records itself since that date.
The two companies
Baxter InternationalBAX
Infusion pumps and the fluids that run through them are the anchor. Baxter also supplies dialysis therapy and products for surgery and acute care.
Full BAX profile →GE HealthCareGEHC
Imaging is the core: CT and MRI systems, plus ultrasound. Patient monitoring equipment and contrast agents round out a range sold worldwide.
Full GEHC profile →More BAX & GEHC comparisons
Other head-to-heads in the Medtech & devices segment.